Public cancer data from sources such as The Cancer Genome Atlas (TCGA) suggest that low FOXQ1 expression levels may similarly be associated with worse survival in other types of cancer, including prostate and urothelial cancer (see, e.g., the Human Protein Atlas pathology resource [37]); however, these associations have not been explored to date. Here, FOXQ1 is linked to cancer.